Suppr超能文献

克罗米芬与依普美罗对血浆孕酮、皮质类固醇结合球蛋白、甲状腺素结合球蛋白和性激素结合球蛋白以及唾液孕酮水平影响的比较研究

A comparative study of clomiphene and epimestrol on plasma progesterone, CBG, TBG and SHBG, and salivary progesterone levels.

作者信息

Kicovic P M, Luisi M, Cortés-Prieto J, Franchi F

出版信息

Reproduccion. 1982 Apr-Jun;6(2):133-40.

PMID:6890485
Abstract

The plasma levels of CBG, TBG, SHBG and progesterone, and salivary progesterone levels were measured in eight young ovulatory volunteers. After the control cycle four subjects received 50 mg/day of Clomiphene from days 5 to 9 of the first treatment cycle, and 10 mg/day of Epimestrol from days 5 to 15 of the second treatment cycle. The other four subjects received the treatments in reverse order. Between the two treatments there was one cycle without medication as a "wash-out" period. Plasma and saliva samples were obtained on days +6, +8 and +10 (day of LH peak was denoted by 0), always between 08.00 and 09.00 h. Statistical evaluation was done by means of an analysis of variance (ANOVA), and correlation coefficients were also calculated. Evaluation of data on effects of Clomiphene and Epimestrol on the plasma levels of CBG and salivary progesterone showed that Clomiphene induced a highly significant rise (p less than 0.001) in the CBG levels and decrease (p less than 0.001) in salivary progesterone levels, while no changes were seen following administration of Epimestrol. Both Clomiphene and Epimestrol treatments led towards higher plasma progesterone levels, those following Clomiphene administration being higher. Neither treatment induced significant changes in TBG or SHBG levels. It is concluded that Clomiphene induces significant elevations of CBG and decrease in salivary progesterone, which is thought to reflect the free progesterone fraction and may have significance in relation to a discrepancy between the ovulation and pregnancy rates following Clomiphene therapy.

摘要

在八名年轻的有排卵的志愿者中测量了皮质类固醇结合球蛋白(CBG)、甲状腺素结合球蛋白(TBG)、性激素结合球蛋白(SHBG)和孕酮的血浆水平以及唾液孕酮水平。在对照周期后,四名受试者在第一个治疗周期的第5至9天接受50毫克/天的克罗米芬治疗,在第二个治疗周期的第5至15天接受10毫克/天的环美雌醇治疗。另外四名受试者接受相反顺序的治疗。在两种治疗之间有一个无药物治疗的周期作为“洗脱”期。在第+6、+8和+10天(LH峰日记为0),总是在08:00至09:00之间采集血浆和唾液样本。通过方差分析(ANOVA)进行统计学评估,并计算相关系数。对克罗米芬和环美雌醇对CBG血浆水平和唾液孕酮影响的数据评估表明,克罗米芬可使CBG水平显著升高(p<0.001),唾液孕酮水平降低(p<0.001),而服用环美雌醇后未见变化。克罗米芬和环美雌醇治疗均使血浆孕酮水平升高,克罗米芬治疗后的水平更高。两种治疗均未引起TBG或SHBG水平的显著变化。结论是,克罗米芬可使CBG显著升高,唾液孕酮降低,这被认为反映了游离孕酮部分,可能与克罗米芬治疗后排卵率和妊娠率之间的差异有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验